Pharmaceutical Products for CDER Research Studies - IDIQ

5/11/2026: Questions and answers: Current or most recent incumbent contractor/vendor name Response: WE Pharma, LLC Previous contract number and/or SAM.gov solicitation number Response: Previous contract number 75F40120D00032 and solicitation number FDASOL1222072. Contract award value or estimated annual spend Response: The prior IDIQ Ceiling was $9,500,000.00. Historical pricing information or awarded pricing structure Response: Historical pricing information and awarded pricing structure are not being provided as part of this solicitation Q&A. Requests for agency records on pricing may be submitted through the applicable FOIA process and will be reviewed for releasability. Period of performance of the incumbent contract Response: 9/30/2020 to 9/29/2025. Any publicly available award documentation or reference links Response: None that we are aware of. 5/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan. See attached combined synopsis/solicitation.

• NAICS325412
• PSC6505

No documents posted for this opportunity.